We are live on
!
Find out more
PCM
Pavaki Capital Management Portfolio holdings
AUM
$287M
This Fund
S&P 500
This Quarter
Est. Return
+12.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow
% of AUM
54.05%
Top 10 Holdings %
Top 10 Hldgs %
57.32%
Holding
131
New
131
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Milestone Pharmaceuticals
MIST
|
+$18.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$13.2M |
| 3 |
ARS Pharmaceuticals
SPRY
|
+$11.4M |
| 4 |
B
Barrick Mining
B
|
+$7.28M |
| 5 |
Walt Disney
DIS
|
+$6.72M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.5% |
| 2 | Healthcare | 29.54% |
| 3 | Materials | 10.85% |
| 4 | Communication Services | 4.97% |
| 5 | Technology | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aquestive Therapeutics
AQST
$596M
| $808K | 0.32% |
+125,000
| New | +$779K |
|
52
Altimmune
ALT
$576M
| $778K | 0.3% |
+215,400
| New | +$939K |
|
53
PUT
Invesco NASDAQ 100 ETF
QQQM
$109B
| $759K | 0.3% |
+3,000
| New | +$758K |
|
54
BlackRock Income Trust
BKT
$309M
| $704K | 0.28% |
+63,810
| New | +$709K |
|
55
Ardelyx
ARDX
$875M
| $670K | 0.26% |
+115,000
| New | +$641K |
|
56
PUT
State Street SPDR S&P Semiconductor ETF
XSD
$3.1B
| $643K | 0.25% |
+2,000
| New | +$660K |
|
57
Biogen
BIIB
$33.6B
| $616K | 0.24% |
+3,500
| New | +$572K |
|
58
Itaú Unibanco
ITUB
$89.2B
| $590K | 0.23% |
+82,400
| New | +$586K |
|
59
CALL
Spotify
SPOT
$101B
| $581K | 0.23% |
+1,000
| New | +$625K |
|
60
OraSure Technologies
OSUR
$263M
| $530K | 0.21% |
+219,033
| New | +$576K |
|
61
The RMR Group
RMR
$313M
| $529K | 0.21% |
+35,500
| New | +$540K |
|
62
CALL
Super Micro Computer
SMCI
$26.9B
| $527K | 0.21% |
+18,000
| New | +$741K |
|
63
Merck
MRK
$368B
| $526K | 0.21% |
+5,000
| New | +$469K |
|
64
Invesco
IVZ
$13.4B
| $525K | 0.21% |
+20,000
| New | +$489K |
|
65
Unicycive Therapeutics
UNCY
$127M
| $519K | 0.2% |
+90,000
| New | +$480K |
|
|
NVO
66
PUT
Novo Nordisk
NVO
$169B
| $509K | 0.2% |
+10,000
| New | +$511K |
|
67
Cooper-Standard Automotive
CPS
$377M
| $492K | 0.19% |
+15,000
| New | +$488K |
|
|
ARIS
68
Aris Mining
ARIS
$3.66B
| $487K | 0.19% |
+30,000
| New | +$369K |
|
69
Toll Brothers
TOL
$12.5B
| $473K | 0.19% |
+3,500
| New | +$475K |
|
70
Lantheus
LNTH
$6.5B
| $473K | 0.19% |
+7,100
| New | +$413K |
|
71
CALL
Sherwin-Williams
SHW
$80.2B
| $454K | 0.18% |
+1,400
| New | +$468K |
|
72
Nokia
NOK
$58B
| $453K | 0.18% |
+70,000
| New | +$434K |
|
73
State Street
STT
$48.8B
| $452K | 0.18% |
+3,500
| New | +$419K |
|
74
iShares MSCI Philippines ETF
EPHE
$132M
| $449K | 0.18% |
+18,000
| New | +$446K |
|
75
PUT
ARK Next Generation Technology ETF
ARKW
$1.93B
| $443K | 0.17% |
+3,000
| New | +$487K |
|
Similar funds
OCM
RSC
MC
QFW
SRWM
ORC
MPAM
AWMT
Pavaki Capital Management's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Pavaki Capital Management, which disclosed 131 positions worth $255M. Its ten largest holdings account for 57% of the portfolio.
Its largest position is Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, followed by Healthcare and Materials.
- Pavaki Capital Management's largest Q4 2025 buy was Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
- Pavaki Capital Management's ten largest holdings make up 57% of its $255M portfolio in Q4 2025.
- Pavaki Capital Management disclosed 131 positions in Q4 2025, its first 13F filing on record.
Based on Pavaki Capital Management's 13F filing for Q4 2025, filed 7 Aug 2026.